Announced Wed, 29 Jul · 20:07 IST
Change in control at Novartis India; ChrysCapital completes takeover
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹1600.00
prior close
₹1610.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.2-0.5-0.5-2.4+2.8+1.8+2.3-0.1+0.2-7.3-1.6——
Up moveDown movePending
AI summary
Novartis AG has sold its 1.74 crore equity shares (controlling stake) in Novartis India to ChrysCapital-backed entities (WaveRise, ChrysCapital Fund X and Two Infinity Partners). The open offer has concluded and WaveRise and Fund X have acquired control. Novartis AG is reclassified from promoter to public. Board reconstituted with new directors appointed and several existing directors resigning.
Likely market impact
Major ownership change. ChrysCapital entities now control Novartis India. Expect strategic shifts as private equity takes charge of the pharma business.